IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
单位:[1]Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Peoples R China[2]Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China[3]Univ Ulsan, Asan Med Ctr, Coll Med, Ulsan, South Korea[4]Univ Hong Kong, Hong Kong, Peoples R China[5]Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China华中科技大学同济医学院附属同济医院[6]Kings Coll Hosp London, London, England[7]Toronto Western Hosp, Toronto, ON, Canada[8]NYU, Sch Med, Langone Med Ctr, New York, NY USA[9]Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan[10]Musashino Red Cross Hosp, Musashino, Tokyo, Japan[11]Toronto Gen Hosp, Toronto, ON, Canada[12]All India Inst Med Sci, New Delhi, India[13]Univ Pisa, Pisa, Italy[14]Gilead Sci, Foster City, CA USA[15]Hop Beaujon, Clichy, France[16]Auckland Clin Studies, Auckland, New Zealand[17]Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China[18]Hosp Univ Valle Hebron, Barcelona, Spain
第一作者单位:[1]Chinese Univ Hong Kong, Dept Med & Therapeut, Inst Digest Dis, Hong Kong, Peoples R China
推荐引用方式(GB/T 7714):
Chan Henry Lik Yuen,Lim Young-Suk,Seto Wai Kay,et al.IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)[J].GUT.2020,69:A75-A76.doi:10.1136/gutjnl-2020-IDDF.144.
APA:
Chan, Henry Lik Yuen,Lim, Young-Suk,Seto, Wai Kay,Ning, Qin,Agarwal, Kosh...&Buti, Maria.(2020).IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB).GUT,69,
MLA:
Chan, Henry Lik Yuen,et al."IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)".GUT 69.(2020):A75-A76